Arcosa (ACA) Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Arcosa in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ACA shares.
View ACA analyst ratings or view top-rated stocks.

2 Wall Street analysts have issued 12-month price objectives for Arcosa's stock. Their ACA share price forecasts range from $65.00 to $85.00. On average, they predict the company's share price to reach $78.75 in the next year. This suggests a possible upside of 13.5% from the stock's current price.
View analysts price targets for ACA or view top-rated stocks among Wall Street analysts.

Arcosa's stock was trading at $54.34 at the start of the year. Since then, ACA shares have increased by 27.7% and is now trading at $69.37.
View the best growth stocks for 2023 here.

Arcosa saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 453,400 shares, a drop of 9.8% from the April 30th total of 502,700 shares. Based on an average daily volume of 268,800 shares, the days-to-cover ratio is currently 1.7 days. Currently, 1.0% of the shares of the company are sold short.
View Arcosa's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 2nd 2023.
View our ACA earnings forecast.

Arcosa, Inc. (NYSE:ACA) released its quarterly earnings data on Friday, April, 28th. The company reported $1.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.50 by $0.56. The company earned $549.20 million during the quarter, compared to the consensus estimate of $499.16 million. Arcosa had a trailing twelve-month return on equity of 6.52% and a net margin of 12.47%. The firm's revenue was up 2.5% compared to the same quarter last year. During the same period in the prior year, the company earned $0.42 EPS.

Arcosa announced a quarterly dividend on Tuesday, May 9th. Investors of record on Friday, July 14th will be given a dividend of $0.05 per share on Monday, July 31st. This represents a $0.20 annualized dividend and a dividend yield of 0.29%. The ex-dividend date is Thursday, July 13th.
Read our dividend analysis for ACA.

ETFs with the largest weight of Arcosa (NYSE:ACA) stock in their portfolio include ProShares S&P Kensho Cleantech ETF (CTEX), First Trust RBA American Industrial Renaissance ETF (AIRR), SPDR S&P Kensho Clean Power ETF (CNRG), Invesco S&P SmallCap Industrials ETF (PSCI), Nuveen Small Cap Select ETF (NSCS), Opus Small Cap Value Plus ETF (OSCV), First Trust Global Wind Energy ETF (FAN) and Invesco S&P SmallCap Momentum ETF (XSMO).

Arcosa (NYSE:ACA) pays an annual dividend of $0.20 per share and currently has a dividend yield of 0.30%. The dividend payout ratio is 3.47%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ACA will have a dividend payout ratio of 6.83% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ACA.

Arcosa updated its FY 2023 earnings guidance on Thursday, April, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $2.20 billion-$2.30 billion, compared to the consensus revenue estimate of $2.19 billion.

15 employees have rated Arcosa Chief Executive Officer Antonio Carrillo on Glassdoor.com. Antonio Carrillo has an approval rating of 91% among the company's employees. This puts Antonio Carrillo in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Arcosa investors own include DexCom (DXCM), AbbVie (ABBV), Walt Disney (DIS), Advanced Micro Devices (AMD), NVIDIA (NVDA), Splunk (SPLK), AT&T (T), Xilinx (XLNX), Activision Blizzard (ATVI) and Alibaba Group (BABA).

Arcosa trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACA."

Arcosa's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (15.74%), Dimensional Fund Advisors LP (5.68%), State Street Corp (4.14%), Royce & Associates LP (3.04%), Geode Capital Management LLC (1.91%) and Silvercrest Asset Management Group LLC (1.77%). Insiders that own company stock include Bryan Stevenson, Gail M Peck, Jesse E Jr Collins, Kerry S Cole, Mary E Henderson and Ronald J Gafford.
View institutional ownership trends.

Shares of ACA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ACA stock can currently be purchased for approximately $69.37.

Arcosa (NYSE:ACA) has a market capitalization of $3.36 billion and generates $2.24 billion in revenue each year. The company earns $245.80 million in net income (profit) each year or $5.77 on an earnings per share basis.

The company employs 5,230 workers across the globe.

Arcosa's mailing address is 500 N. Akard Street Suite 400, DALLAS TX, 75201. The official website for the company is www.arcosa.com. The company can be reached via phone at (972) 942-6500 or via email at investorresources@arcosa.com.